Skip to content
Equities Orbis

Equities Orbis

Stocks of the World, Revealed.

  • AI
  • Software
  • Utilities
  • Commodities
  • Space
  • Biotech
  • Industrials
  • Construction
  • Financials
  • Opinion
  • Macro
  • Crypto
  • Quantum

Recent Analysis

View All

Surviving the Semiconductor Massacre: Why Nvidia is the Ultimate Buy-the-Dip Opportunity

Cassian Vance June 6, 2026June 6, 2026

The Green Rush to Wall Street: Trulieve Cannabis Secures Historic NYSE Uplisting

Julia Rostova June 6, 2026June 6, 2026

The $1.75 Trillion Question: Is the SpaceX IPO the Ultimate AI Play or the Greatest Tech Bubble?

Julia Rostova June 6, 2026

Biogen: A Transitional Powerhouse Navigating the Post-Aduhelm Era

Ralph Sun June 4, 2026

Navigating the Crossroads for Regeneron Pharmaceuticals

Ralph Sun June 4, 2026

Highlights

AI

Surviving the Semiconductor Massacre: Why Nvidia is the Ultimate Buy-the-Dip Opportunity

Friday, June 5, 2026, will be remembered as the day the great semiconductor reckoning arrived.…

Cassian Vance June 6, 2026June 6, 2026
Biotech

The Green Rush to Wall Street: Trulieve Cannabis Secures Historic NYSE Uplisting

The United States cannabis sector is standing on the precipice of a monumental shift. For…

Julia Rostova June 6, 2026June 6, 2026
Space

The $1.75 Trillion Question: Is the SpaceX IPO the Ultimate AI Play or the Greatest Tech Bubble?

On June 12, 2026, the financial markets will witness an event of unprecedented scale. SpaceX…

Julia Rostova June 6, 2026

Editor's Choice

View All
Opinion

The Cresting Wave: Signs Your Momentum Strategy Is About to Go Bust

Ralph Sun May 18, 2026May 18, 2026
Software

The End of the SaaSpocalypse: Why ServiceNow is the Ultimate AI Recovery Trade

Ralph Sun May 30, 2026May 30, 2026
The GLP-1 Pill Wars: Novo Nordisk’s Comeback and the $100B Obesity Market
Biotech

The GLP-1 Pill Wars: Novo Nordisk’s Comeback and the $100B Obesity Market

Julia RostovaMay 6, 2026

The pharmaceutical landscape is currently dominated by a single, revolutionary class of drugs: GLP-1 receptor agonists. What began as a…

The AI Trade Intensifies: Decoding Palantir’s Blowout Quarter and the New Winners
AI

The AI Trade Intensifies: Decoding Palantir’s Blowout Quarter and the New Winners

Cassian VanceMay 5, 2026

The artificial intelligence narrative continues to dominate equity markets, but the focus has definitively shifted from theoretical potential to tangible…

The Geopolitical Premium: Navigating the 2026 Oil Shock
Energy

The Geopolitical Premium: Navigating the 2026 Oil Shock

Julia RostovaMay 5, 2026May 5, 2026

Global energy markets are currently experiencing a seismic shift, driven by a confluence of escalating geopolitical tensions and structural supply…

SoundHound AI: Voice of the Future, or Just Another Speculative Whisper?
AI

SoundHound AI: Voice of the Future, or Just Another Speculative Whisper?

Cassian VanceMay 5, 2026May 5, 2026

The artificial intelligence revolution has reshaped the software landscape, minting new market darlings and leaving legacy players scrambling to adapt.…

C3.ai Has the Perfect Ticker—But Does It Have a Viable Business?
AI

C3.ai Has the Perfect Ticker—But Does It Have a Viable Business?

Cassian VanceMay 5, 2026May 5, 2026

In the frenzied landscape of artificial intelligence investments, having the right name can sometimes feel like half the battle. For…

Datadog: The Quiet AI Winner Hiding in Plain Sight?
AI

Datadog: The Quiet AI Winner Hiding in Plain Sight?

Cassian VanceMay 4, 2026May 4, 2026

When investors think of artificial intelligence software, the conversation inevitably gravitates toward the flashy names. Palantir dominates the defense narrative,…

Snowflake at a Crossroads: Bargain Data Cloud Play or a Growth Story Losing Steam?
Software

Snowflake at a Crossroads: Bargain Data Cloud Play or a Growth Story Losing Steam?

Cassian VanceMay 4, 2026May 4, 2026

Snowflake Inc. (NYSE: SNOW), a prominent player in the data cloud sector, finds itself at a pivotal juncture. After years…

Can Palantir Justify Its Valuation, or Is It Riding Pure AI Hype?
Software

Can Palantir Justify Its Valuation, or Is It Riding Pure AI Hype?

Cassian VanceMay 3, 2026May 3, 2026

The artificial intelligence revolution has produced its fair share of market darlings, but perhaps none as polarizing or fiercely debated…

CrowdStrike’s AI Fortress: Can the Cybersecurity Giant Fend Off a New Wave of Threats?
AI

CrowdStrike’s AI Fortress: Can the Cybersecurity Giant Fend Off a New Wave of Threats?

Cassian VanceMay 3, 2026May 3, 2026

The cybersecurity landscape is undergoing a profound and rapid transformation, driven primarily by the relentless advancement of artificial intelligence. At…

Is Cameco Priced for Perfection in a Volatile Uranium Market?
Energy

Is Cameco Priced for Perfection in a Volatile Uranium Market?

Julia RostovaApril 30, 2026April 30, 2026

The global narrative surrounding nuclear energy has shifted dramatically over the past several years. Driven by the dual imperatives of…

Is Oklo Trading on AI Hype or Real Nuclear Innovation?
Energy

Is Oklo Trading on AI Hype or Real Nuclear Innovation?

Julia RostovaApril 30, 2026April 30, 2026

The intersection of artificial intelligence and nuclear energy has created a new breed of market darlings, and few companies exemplify…

Posts pagination

Previous 1 … 9 10 11 … 14 Next
Equities Orbis
  • About Us
  • Contact
  • Submit Your Post
OT Media Inc.

The AI Oracle

Crypto Sybil

Equities Orbis

OT Public Relations

Copyright © 2026 Equities Orbis